BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Glaxosmithkline Pharmaceuticals Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500660
ISIN Demat
INE159A01016
Book Value (Rs)
132.2958859
NSE Symbol
GLAXO
Divident Yield %
2.69
Market Cap
(Rs In Cr.)
35,926
P/E (TTM)
39.57
EPS (TTM)
53.59
Face Value
(Rs)
10
Back
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
09-Feb-26   Hrs IST

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales1041.26949.42 10
OPM %35.6630.75 -
PBDT402.27326.90 23
PBT381.95308.10 24
NP295.62229.88 29

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)